Study Information
For more details on our studies, please follow the links below:
Cancer Care Institute
Research studies
Walking Forward
Regional Health Clinical Research
Endocrinology
DEFEND-2 (Type I Diabetes-Ages 12-45)
Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
TTEDD (Type I Diabetes-Ages 12-45)
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (TTEDD)
DIAMYD (Type I Diabetes-Ages 10-20)
A Phase III, 3-Arm, Randomized, Double-Blind,Placebo-Controlled, Multicenter Study, to Investigate the Impact of Diamyd® on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus.
IGFD Registry (Diabetes Registry)
Increlex™ (mecasermin [rDNA origin] injection) Growth Forum Database – IGFD Registry: A Patient Registry for Monitoring Long-Term Safety and Efficacy of Increlex™
Veracyte (Thyroid FNA)
VERA001: Molecular Profiling Analysis of Indeterminate Thyroid Nodule Fine Needle Aspirates to Determine Patterns Predictive of Benign or Malignant Disease
Infectious Disease
ACAM CDIFF (Clostridium Difficile-Adults)
A Phase II Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of A Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection (CDI)
CASG 301 (Influenza (flu) Natural History-Ages 1 Day-100)
An Observational Study of the Clinical and Virologic Manifestation of Novel and Seasonal Influenza
Cubist LCD-DR-09-03 (Cdiff – Ages 18 and Up)
Study of CB-183,315 in Patients With Clostridium Difficile Infection